Wednesday, October 20, 2021

Sales of Biogen’s costly new Alzheimer’s drug fall far short of expectations.


By BY REBECCA ROBBINS from NYT Business https://ift.tt/3n9yBwd

No comments:

Post a Comment

By Unknown Author from NYT U.S. https://ift.tt/3qTt5iZ